Last SFr.253.10 CHF
Change Today +2.40 / 0.96%
Volume 1.4M
As of 11:43 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Severin Schwan

Chief Executive Officer and Director, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 31 board members in 3 different organizations across 10 different industries.

See Board Relationships
45SFr.13,212,000
As of Fiscal Year 2012

Background*

Dr. Severin Schwan serves as the Chief Executive Officer of F. Hoffmann-La Roche Ltd. Dr. Schwan serves as the Chief Executive Officer of Roche Diabetes Care AG. Dr. Schwan has been the Group Chief Executive Officer of Roche Holding AG at Roche Pharma AG and Roche Pharmholding B.v. since March 2008. He serves as Chief Executive Officer of Roche Group. He served as the Group Chief Executive Officer of Roche Diagnostics Corporation, a Diagnostics Divisions of Roche Holding ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Director
Former Director
2008-Present
Director
2013-Present
Chief Executive Officer and Director

Education*

Bachelor's Degree
University of Oxford
LLB 1991
Universität Innsbruck
Bachelor's Degree 1991
Universität Innsbruck
Bachelor's Degree
University of York
Doctorate 1993
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

SalarySFr.4,000,000
BonusSFr.2,513,000
Total Annual CompensationSFr.6,513,000

Stock Options*

All Other CompensationSFr.6,699,000
Total Value of OptionsSFr.13,800,668
Total Number of Options623,096

Total Compensation*

Total Annual Cash CompensationSFr.13,212,000
Total Short Term CompensationSFr.6,513,000
Other Long Term CompensationSFr.6,699,000
Total Calculated CompensationSFr.13,212,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.253.10 CHF +2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.7M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
1.9M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.4M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.5M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.